Stay updated on Flotetuzumab EAP in AML: Investigational Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.

Latest updates to the Flotetuzumab EAP in AML: Investigational Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe Record History now includes a new revision entry (v3.6.4) and removes the previous revision (v3.6.3); this indicates a back-end update to the page's versioning rather than a change to visible study information.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry v3.6.3 was added to the history. The previous v3.6.2 entry was removed, updating the study record's revision log.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry, v3.6.2, was added to the study's record history, and the older v3.6.0 entry was removed from the list.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry v3.6.0 was added to the study's record history, and the previous revision v3.5.5 was removed, reflecting an update to the page's versioning.SummaryDifference0.3%

- Check60 days agoChange DetectedA new revision entry v3.5.5 was added to the page's history, and the previous revision v3.5.4 was removed from the list. This updates the version history to reflect the latest revision.SummaryDifference0.1%

- Check81 days agoChange DetectedRecord History now shows a new revision entry, v3.5.4, indicating an update to the study record's revision history. The previous entry, v3.5.3, is removed from the current history view.SummaryDifference0.1%

Stay in the know with updates to Flotetuzumab EAP in AML: Investigational Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.